IRCT20121021011192N7RecruitingPhase 3
comparison of the effect of buccal buspirone administration with placebo in improvement of clinical symptoms in GERD patients
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 58
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15 years to no limit (—)
- Sex
- All
Inclusion Criteria
- •GERD disease in patients with more than 15 years old
Exclusion Criteria
- •History of confirmed hypersensitivity reaction to buspirone or omeprazol or any parts of formulation of buccal buspirone
- •eGFR less than 10 ml/min/1.73m2
- •Liver failure (child pugh C)
- •Pregnancy & lactation
- •Concurrent use of thalidomide/ dapoxetine/MAOI/ conivaptane , tolvaptane/
Investigators
Similar Trials
Recruiting
Phase 3
The effect of adding buspirone to SSRIs in the treatment of obsessive-compulsive disorderObsessive-compulsive disorderIRCT20180303038927N1Qazvin University of Medical Sciences60
Recruiting
Phase 3
Comparison of the efficacy of Buspirone and placebo in functional abdominal pain in childreFunctional abdominal pain.Unspecified abdominal painIRCT20140304016844N3Esfahan University of Medical Sciences100
Recruiting
Phase 3
Evaluation of the therapeutic effect of buspirone in improving the dysphagia of patients with ineffective esophageal motility.IRCT20210418051005N1Tehran University of Medical Sciences50
Recruiting
Not Applicable
Comparison of sublingual buprenorphine and intravenous fentanyl pump for cesarean section pain controlcaesarean section.Delivery by elective caesarean sectionIRCT2017081723559N14Vice chancellor for research, Ardabil University of Medical Sciences100
Not yet recruiting
Phase 1
A study on two different doses of buprenorphine with levobupivacaine in abdoiminal nerve block for pain relief in inguinal hernia surgeriesCTRI/2024/06/068392Dr srirama krishnan